InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
T+90 hit rate
50%
T+90 mean return
-3.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Currie Mark G, Director. Director active across 1 company, notably Ironwood Pharmaceuticals INC. Cumulatively, 11 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €1.3m. Activity tracked since 2 June 2021. The latest transaction was filed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
63,481 sharesClass A Common StockSEC:0001193125-26-274288:0
24,311 shares0Class A Common StockSEC:0000950170-24-076206:0
22,350 shares0Class A Common StockSEC:0001209191-23-039132:0
70,000 shares@ US$11.7824.1% of flowClass A Common StockSEC:0001209191-22-045808:0
190,383 shares@ US$11.650.35% mcap82.1% of flowClass A Common StockSEC:0001209191-22-035443:0
21,571 shares0Class A Common StockSEC:0001209191-22-033983:0
23,571 shares@ US$11.596.8% of flowClass A Common StockSEC:0001209191-21-040892
23,571 shares@ US$11.590.038% mcap8.9% of flowClass A Common StockSEC:0001209191-21-040892:0
22,766 shares0Class A Common StockSEC:0001209191-21-038179:0
22,766 shares0Class A Common StockSEC:0001209191-21-038179
64,102 sharesClass B Common StockSEC:0001209191-16-090084:0
11 of 11 declarations
About Currie Mark G
Mark G. Currie serves as a board member at IRONWOOD PHARMACEUTICALS INC. He contributes to the strategic direction of the company, ensuring that decisions made within the board align with growth objectives. His expertise in the pharmaceutical sector is a valuable asset.
